Phosphocreatine system — MRCP Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Severe neutropenia from antithyroid-drug agranulocytosis
The best answer is “Severe neutropenia from antithyroid-drug agranulocytosis”. This symptom cluster during antithyroid treatment is characteristic of potentially fatal agranulocytosis. Propylthiouracil is stopped and an urgent full blood count obtained; the patient needs prompt clinical assessment and must not restart an antithyroid drug without specialist advice. Hypothyroidism, eye disease and adrenergic symptoms do not explain the infection phenotype.
Reference: NHS Specialist Pharmacy Service: Propylthiouracil monitoring: https://www.sps.nhs.uk/monitorings/propylthiouracil-monitoring/